Discordant effects of rasagiline doses in Parkinson disease

被引：4

作者：

Deftereos, Spyros N. ^{[1
]}

Andronis, Christos A. ^{[1
]}

机构：

[1] Biovista Inc, Charlottesville, VA 22902 USA

来源：

NATURE REVIEWS NEUROLOGY | 2010年 / 6卷 / 07期

关键词：

DOUBLE-BLIND; TRIAL;

D O I：

10.1038/nrneurol.2010.2-c1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1 / 1

页数：1

共 6 条

[1] Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease [J].

Blandini, F ;

Armentero, MT ;

Fancellu, R ;

Blaugrund, E ;

Nappi, G .

EXPERIMENTAL NEUROLOGY, 2004, 187 (02) :455-459

[2] A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease [J].

Olanow, C. Warren ;

Rascol, Olivier ;

Hauser, Robert ;

Feigin, Paul D. ;

Jankovic, Joseph ;

Lang, Anthony ;

Langston, William ;

Melamed, Eldad ;

Poewe, Werner ;

Stocchi, Fabrizio ;

Tolosa, Eduardo .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1268-1278

[3] Glyceraldehyde-3-Phosphate Dehydrogenase-Monoamine Oxidase B-Mediated Cell Death-Induced by Ethanol is Prevented by Rasagiline and 1-R-Aminoindan [J].

Ou, Xiao-Ming ;

Lu, Deyin ;

Johnson, Chandra ;

Chen, Kevin ;

Youdim, Moussa B. H. ;

Rajkowska, Grazyna ;

Shih, Jean C. .

NEUROTOXICITY RESEARCH, 2009, 16 (02) :148-159

[4] Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa [J].

Rabey, JM ;

Sagi, I ;

Huberman, M ;

Melamed, E ;

Korczyn, A ;

Giladi, N ;

Inzelberg, R ;

Djaldetti, R ;

Klein, C ;

Berecz, G .

CLINICAL NEUROPHARMACOLOGY, 2000, 23 (06) :324-330

[5] PARKINSON DISEASE ADAGIO trial hints that rasagiline slows disease progression [J].

Sampaio, Cristina ;

Ferreira, Joaquim J. .

NATURE REVIEWS NEUROLOGY, 2010, 6 (03) :126-128

[6]

Youdim MBH, 2010, NEW ENGL J MED, V362, P657, DOI 10.1056/NEJMc0910491

← 1 →